Sage Journals: Discover world-class research

Free access

Review article

First published 2012-4

Efficacy and safety of ultra-long-acting insulin degludec

Ammar Wakil, Stephen L. Atkin

Therapeutic Advances in Endocrinology and Metabolism

Free access

Review article

First published 2015-11

Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus

Stephen Atkin, Zeeshan Javed, Gregory Fulcher

Sage Open Chronic Disease

Open access

Review article

First published 2012

Insulin Degludec,The New Generation Basal Insulin or Just another Basal Insulin?

Sami N. Nasrallah, L. Raymond Reynolds

Clinical Medicine Insights: Endocrinology and Diabetes

Free access

Research article

First published 2015-12-18

Insulin Degludec Requires Lower Bolus Insulin Doses Than Does Insulin Glargine in Japanese Diabetic Patients With Insulin-Dependent State

Manaho Komuro, Gaku Inoue, Mitsuhisa Tabata [...]

Journal of Diabetes Science and Technology

Retricted access

Review article

First published 2018-1

The Clinical Use of a Fixed-Dose Combination of Insulin Degludec and Liraglutide (Xultophy 100/3.6) for the Treatment of Type 2 Diabetes

Kira Harris, Kimberly Lovin Nealy

Annals of Pharmacotherapy

Free access

Research article

First published 2023-1

Effects of Aerobic Exercise on Systemic Insulin Degludec Concentrations in People with Type 1 Diabetes

David Herzig, Michael Groessl, Mario Álvarez-Martínez [...]

Journal of Diabetes Science and Technology

Retricted access

Research article

First published 2013-2

Insulin Degludec: A Novel Basal Insulin Analogue

Jennifer D Goldman-Levine, Dhiren K Patel, David M Schnee

Annals of Pharmacotherapy

Free access

Research article

First published 2019-5

Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478)

Athena Philis-Tsimikas, Irene Stratton, Lone Nørgård Troelsen [...]

Journal of Diabetes Science and Technology

Retricted access

Research article

First published 2019-3

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Free access

Letter

First published 2018-5

Severe Hypoglycemia in Adults With Type 1 Diabetes After Switching to Insulin Degludec

Halis Kaan Akturk, Viral N. Shah

Journal of Diabetes Science and Technology

Search results